Treatment Registry
TR-0120 ActiveRecorded September 2026Last verified October 2026

Compounded tirzepatide

Sold by RxSpan MD · Injection, vial · every compounded tirzepatide record

Recorded initial charges

First month

$329

first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.

Medication · Regular monthly price · recorded initial monthly payment$329

Added from the figures recorded below.

Price

TermPer monthCharged today
Regular monthly priceAdvertised

“Tirzepatide Injection Learn More | Compare Medications Regular Monthly Price $329 As low as $243/mo 12-month plan, billed as one upfront payment of $2,905. STARTNOW promo applied. Auto-renews. Final price confirmed at checkout.”

Per month$329Charged today$329
12-month plan paid upfront, STARTNOW promo

Price conditions have not been established; the quoted figure is not a verified recurring rate.

STARTNOW promotional terms and selected-plan total require confirmation; advertised rounded monthly amount is not multiplied to compute the invoice.

“Tirzepatide Injection Learn More | Compare Medications Regular Monthly Price $329 As low as $243/mo 12-month plan, billed as one upfront payment of $2,905. STARTNOW promo applied. Auto-renews. Final price confirmed at checkout.”

Per month$243Charged today$2,905
Price sources
Enroll with RxSpan MD

This is a paid link. If you enroll through it, Treatment Registry may earn a commission. It does not change what we record, and it does not change the price you pay.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PharmacyNot disclosed
StatesNot disclosed
PrescriberBoth
CancellationThe catalogue permits cancellation or plan changes, but this does not establish a refund of unused prepaid months. The reviewed general terms do not provide a refund schedule. Reviewed 2026-10-07: https://www.rxspanmd.com/category/weight-loss and https://www.rxspanmd.com/legal/terms-of-service
MembershipNot disclosed
Consult feeIncluded in program price; itemized amount is not published. The program includes consultation, medication, supplies, shipping and support.

Recorded from rxspanmd.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — Every discounted figure on RxSpan's weight-loss page depends on a promotion. The cards read “STARTNOW promo applied” and “Final price confirmed at checkout”, so the unconditional number is the one labeled Regular Monthly Price. The discounted rungs are recorded with the promo named in their label.
  2. 2. September 2026 — RxSpan prices tirzepatide capsules at $349 a month and the injection at $329, but both cards give the same discounted figure of $243 a month and the same 12-month total of $2,905. The page does not explain how two different monthly prices reach an identical annual one.
  3. 3. October 2026 — RxSpan includes clinician consultation, medication, supplies, shipping and support. Its intake can be reviewed without an appointment; an additional telehealth visit may be requested. The named pharmacy network includes Belmar, Strive, Epiq Scripts and Casa Pharma Rx, but the page does not assign a dispenser to this program. Nationwide care is advertised with a specific-services caveat, so confirm availability for your state. Annual promotional cards quote exact prepaid totals alongside rounded monthly figures; the discount is not confirmed for renewals. Canceling future orders does not establish a refund of unused prepaid months.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0120
Medication category
compounded tirzepatide
Readings
3

Related records

Other records from RxSpan MD

All RxSpan MD programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 374 records of the same molecule.

Side by side

Cite this entry

Treatment Registry. (2026). RxSpan MD — compounded tirzepatide (TR-0120). Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0120

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.